APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radioisotopes in Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Radioisotopes in Medicine Market Analysis and Forecast 2026-2032

1 February 2026217 pages

Choose your research edition.

Industry ResearchRadioisotopes in Medicine Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Radioisotopes in Medicine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Radioisotopes in Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radioisotopes in Medicine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Radioisotopes in Medicine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Radioisotopes in Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Radioisotopes in Medicine's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned ANSTO as the global sales leader, a title it has maintained for several consecutive years. Notably, ANSTO's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.

The major global manufacturers in the Radioisotopes in Medicine market include ANSTO, China National Nuclear Corporation, Eckert & Ziegler Strahlen, IRE, Nordion, NorthStar Medical Radioisotopes, NRG, NTP Radioisotopes and Polatom, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Radioisotopes in Medicine production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Radioisotopes in Medicine by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Radioisotopes in Medicine, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radioisotopes in Medicine, also provides the consumption of main regions and countries. Of the upcoming market potential for Radioisotopes in Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radioisotopes in Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radioisotopes in Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Radioisotopes in Medicine sales, projected growth trends, production technology, application and end-user industry.

Radioisotopes in Medicine Segment by Company

ANSTO

China National Nuclear Corporation

Eckert & Ziegler Strahlen

IRE

Nordion

NorthStar Medical Radioisotopes

NRG

NTP Radioisotopes

Polatom

Rosatom

SHINE Technologies

Radioisotopes in Medicine Segment by Type

Tc-99m

Iodine Radioisotopes

Cobalt-60

Others

Radioisotopes in Medicine Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Radioisotopes in Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioisotopes in Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radioisotopes in Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioisotopes in Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Radioisotopes in Medicine production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Radioisotopes in Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Radioisotopes in Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radioisotopes in Medicine sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radioisotopes in Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tc-99m Major Manufacturers Table 3. Iodine Radioisotopes Major Manufacturers Table 4. Cobalt-60 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Radioisotopes in Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Nuclear Therapy Major Manufacturers Table 8. Equipment Radioactive Source Major Manufacturers Table 9. Diagnosis Major Manufacturers Table 10. Radioisotopes in Medicine Industry Trends Table 11. Radioisotopes in Medicine Industry Drivers Table 12. Radioisotopes in Medicine Industry Opportunities and Challenges Table 13. Radioisotopes in Medicine Industry Restraints Table 14. Global Radioisotopes in Medicine Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 15. Global Radioisotopes in Medicine Production by Region (2021-2026) & (t) Table 16. Global Radioisotopes in Medicine Production by Region (2027-2032) & (t) Table 17. Global Radioisotopes in Medicine Production Market Share by Region (2021-2026) Table 18. Global Radioisotopes in Medicine Production Market Share by Region (2027-2032) Table 19. Global Radioisotopes in Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Radioisotopes in Medicine Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Radioisotopes in Medicine Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Radioisotopes in Medicine Revenue Market Share by Region (2021-2026) Table 23. Global Radioisotopes in Medicine Revenue Market Share by Region (2027-2032) Table 24. Global Radioisotopes in Medicine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 25. Global Radioisotopes in Medicine Sales by Region (2021-2026) & (t) Table 26. Global Radioisotopes in Medicine Sales by Region (2027-2032) & (t) Table 27. Global Radioisotopes in Medicine Sales Market Share by Region (2021-2026) Table 28. Global Radioisotopes in Medicine Sales Market Share by Region (2027-2032) Table 29. Global Radioisotopes in Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Radioisotopes in Medicine Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Radioisotopes in Medicine Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Radioisotopes in Medicine Sales Market Share by Manufacturers (2021-2026) Table 33. Global Radioisotopes in Medicine Sales Price (USD/t) of Manufacturers (2021-2026) Table 34. Global Radioisotopes in Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Radioisotopes in Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Radioisotopes in Medicine Manufacturers, Product Type & Application Table 37. Global Radioisotopes in Medicine Manufacturers Commercialization Time Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Radioisotopes in Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 40. Global Radioisotopes in Medicine Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Radioisotopes in Medicine Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Radioisotopes in Medicine Revenue Market Share by Type (2021-2026) Table 43. Global Radioisotopes in Medicine Revenue Market Share by Type (2027-2032) Table 44. Global Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 45. Global Radioisotopes in Medicine Sales by Type (2027-2032) & (t) Table 46. Global Radioisotopes in Medicine Sales Market Share by Type (2021-2026) Table 47. Global Radioisotopes in Medicine Sales Market Share by Type (2027-2032) Table 48. Global Radioisotopes in Medicine Price by Type (2021-2026) & (USD/t) Table 49. Global Radioisotopes in Medicine Price by Type (2027-2032) & (USD/t) Table 50. Global Radioisotopes in Medicine Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Radioisotopes in Medicine Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Radioisotopes in Medicine Revenue Market Share by Application (2021-2026) Table 53. Global Radioisotopes in Medicine Revenue Market Share by Application (2027-2032) Table 54. Global Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 55. Global Radioisotopes in Medicine Sales by Application (2027-2032) & (t) Table 56. Global Radioisotopes in Medicine Sales Market Share by Application (2021-2026) Table 57. Global Radioisotopes in Medicine Sales Market Share by Application (2027-2032) Table 58. Global Radioisotopes in Medicine Price by Application (2021-2026) & (USD/t) Table 59. Global Radioisotopes in Medicine Price by Application (2027-2032) & (USD/t) Table 60. ANSTO Company Information Table 61. ANSTO Business Overview Table 62. ANSTO Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 63. ANSTO Radioisotopes in Medicine Product Portfolio Table 64. ANSTO Recent Development Table 65. China National Nuclear Corporation Company Information Table 66. China National Nuclear Corporation Business Overview Table 67. China National Nuclear Corporation Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio Table 69. China National Nuclear Corporation Recent Development Table 70. Eckert & Ziegler Strahlen Company Information Table 71. Eckert & Ziegler Strahlen Business Overview Table 72. Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio Table 74. Eckert & Ziegler Strahlen Recent Development Table 75. IRE Company Information Table 76. IRE Business Overview Table 77. IRE Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. IRE Radioisotopes in Medicine Product Portfolio Table 79. IRE Recent Development Table 80. Nordion Company Information Table 81. Nordion Business Overview Table 82. Nordion Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Nordion Radioisotopes in Medicine Product Portfolio Table 84. Nordion Recent Development Table 85. NorthStar Medical Radioisotopes Company Information Table 86. NorthStar Medical Radioisotopes Business Overview Table 87. NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio Table 89. NorthStar Medical Radioisotopes Recent Development Table 90. NRG Company Information Table 91. NRG Business Overview Table 92. NRG Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. NRG Radioisotopes in Medicine Product Portfolio Table 94. NRG Recent Development Table 95. NTP Radioisotopes Company Information Table 96. NTP Radioisotopes Business Overview Table 97. NTP Radioisotopes Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. NTP Radioisotopes Radioisotopes in Medicine Product Portfolio Table 99. NTP Radioisotopes Recent Development Table 100. Polatom Company Information Table 101. Polatom Business Overview Table 102. Polatom Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Polatom Radioisotopes in Medicine Product Portfolio Table 104. Polatom Recent Development Table 105. Rosatom Company Information Table 106. Rosatom Business Overview Table 107. Rosatom Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. Rosatom Radioisotopes in Medicine Product Portfolio Table 109. Rosatom Recent Development Table 110. SHINE Technologies Company Information Table 111. SHINE Technologies Business Overview Table 112. SHINE Technologies Radioisotopes in Medicine Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. SHINE Technologies Radioisotopes in Medicine Product Portfolio Table 114. SHINE Technologies Recent Development Table 115. North America Radioisotopes in Medicine Revenue by Type (2021-2026) & (US$ Million) Table 116. North America Radioisotopes in Medicine Revenue by Type (2027-2032) & (US$ Million) Table 117. North America Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 118. North America Radioisotopes in Medicine Sales by Type (2027-2032) & (t) Table 119. North America Radioisotopes in Medicine Sales Price by Type (2021-2026) & (USD/t) Table 120. North America Radioisotopes in Medicine Sales Price by Type (2027-2032) & (USD/t) Table 121. North America Radioisotopes in Medicine Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Radioisotopes in Medicine Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 124. North America Radioisotopes in Medicine Sales by Application (2027-2032) & (t) Table 125. North America Radioisotopes in Medicine Sales Price by Application (2021-2026) & (USD/t) Table 126. North America Radioisotopes in Medicine Sales Price by Application (2027-2032) & (USD/t) Table 127. North America Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America Radioisotopes in Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. North America Radioisotopes in Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. North America Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032) & (t) Table 131. North America Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 132. North America Radioisotopes in Medicine Sales by Country (2027-2032) & (t) Table 133. North America Radioisotopes in Medicine Sales Price by Country (2021-2026) & (USD/t) Table 134. North America Radioisotopes in Medicine Sales Price by Country (2027-2032) & (USD/t) Table 135. United States Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 136. Canada Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 137. Mexico Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 138. Europe Radioisotopes in Medicine Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Radioisotopes in Medicine Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 141. Europe Radioisotopes in Medicine Sales by Type (2027-2032) & (t) Table 142. Europe Radioisotopes in Medicine Sales Price by Type (2021-2026) & (USD/t) Table 143. Europe Radioisotopes in Medicine Sales Price by Type (2027-2032) & (USD/t) Table 144. Europe Radioisotopes in Medicine Revenue by Application (2021-2026) & (US$ Million) Table 145. Europe Radioisotopes in Medicine Revenue by Application (2027-2032) & (US$ Million) Table 146. Europe Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 147. Europe Radioisotopes in Medicine Sales by Application (2027-2032) & (t) Table 148. Europe Radioisotopes in Medicine Sales Price by Application (2021-2026) & (USD/t) Table 149. Europe Radioisotopes in Medicine Sales Price by Application (2027-2032) & (USD/t) Table 150. Europe Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. Europe Radioisotopes in Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. Europe Radioisotopes in Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. Europe Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032) & (t) Table 154. Europe Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 155. Europe Radioisotopes in Medicine Sales by Country (2027-2032) & (t) Table 156. Europe Radioisotopes in Medicine Sales Price by Country (2021-2026) & (USD/t) Table 157. Europe Radioisotopes in Medicine Sales Price by Country (2027-2032) & (USD/t) Table 158. Germany Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 159. France Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 160. U.K. Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 161. Italy Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 162. Russia Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 163. Spain Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 164. Netherlands Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 165. Switzerland Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 166. Sweden Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 167. Poland Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 168. China Radioisotopes in Medicine Revenue by Type (2021-2026) & (US$ Million) Table 169. China Radioisotopes in Medicine Revenue by Type (2027-2032) & (US$ Million) Table 170. China Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 171. China Radioisotopes in Medicine Sales by Type (2027-2032) & (t) Table 172. China Radioisotopes in Medicine Sales Price by Type (2021-2026) & (USD/t) Table 173. China Radioisotopes in Medicine Sales Price by Type (2027-2032) & (USD/t) Table 174. China Radioisotopes in Medicine Revenue by Application (2021-2026) & (US$ Million) Table 175. China Radioisotopes in Medicine Revenue by Application (2027-2032) & (US$ Million) Table 176. China Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 177. China Radioisotopes in Medicine Sales by Application (2027-2032) & (t) Table 178. China Radioisotopes in Medicine Sales Price by Application (2021-2026) & (USD/t) Table 179. China Radioisotopes in Medicine Sales Price by Application (2027-2032) & (USD/t) Table 180. Asia Radioisotopes in Medicine Revenue by Type (2021-2026) & (US$ Million) Table 181. Asia Radioisotopes in Medicine Revenue by Type (2027-2032) & (US$ Million) Table 182. Asia Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 183. Asia Radioisotopes in Medicine Sales by Type (2027-2032) & (t) Table 184. Asia Radioisotopes in Medicine Sales Price by Type (2021-2026) & (USD/t) Table 185. Asia Radioisotopes in Medicine Sales Price by Type (2027-2032) & (USD/t) Table 186. Asia Radioisotopes in Medicine Revenue by Application (2021-2026) & (US$ Million) Table 187. Asia Radioisotopes in Medicine Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 189. Asia Radioisotopes in Medicine Sales by Application (2027-2032) & (t) Table 190. Asia Radioisotopes in Medicine Sales Price by Application (2021-2026) & (USD/t) Table 191. Asia Radioisotopes in Medicine Sales Price by Application (2027-2032) & (USD/t) Table 192. Asia Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Radioisotopes in Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Asia Radioisotopes in Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Asia Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032) & (t) Table 196. Asia Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 197. Asia Radioisotopes in Medicine Sales by Country (2027-2032) & (t) Table 198. Asia Radioisotopes in Medicine Sales Price by Country (2021-2026) & (USD/t) Table 199. Asia Radioisotopes in Medicine Sales Price by Country (2027-2032) & (USD/t) Table 200. Japan Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 201. South Korea Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 202. India Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 203. Australia Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 204. Taiwan Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 205. Southeast Asia Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 206. SAMEA Radioisotopes in Medicine Revenue by Type (2021-2026) & (US$ Million) Table 207. SAMEA Radioisotopes in Medicine Revenue by Type (2027-2032) & (US$ Million) Table 208. SAMEA Radioisotopes in Medicine Sales by Type (2021-2026) & (t) Table 209. SAMEA Radioisotopes in Medicine Sales by Type (2027-2032) & (t) Table 210. SAMEA Radioisotopes in Medicine Sales Price by Type (2021-2026) & (USD/t) Table 211. SAMEA Radioisotopes in Medicine Sales Price by Type (2027-2032) & (USD/t) Table 212. SAMEA Radioisotopes in Medicine Revenue by Application (2021-2026) & (US$ Million) Table 213. SAMEA Radioisotopes in Medicine Revenue by Application (2027-2032) & (US$ Million) Table 214. SAMEA Radioisotopes in Medicine Sales by Application (2021-2026) & (t) Table 215. SAMEA Radioisotopes in Medicine Sales by Application (2027-2032) & (t) Table 216. SAMEA Radioisotopes in Medicine Sales Price by Application (2021-2026) & (USD/t) Table 217. SAMEA Radioisotopes in Medicine Sales Price by Application (2027-2032) & (USD/t) Table 218. SAMEA Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. SAMEA Radioisotopes in Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. SAMEA Radioisotopes in Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. SAMEA Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032) & (t) Table 222. SAMEA Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 223. SAMEA Radioisotopes in Medicine Sales by Country (2027-2032) & (t) Table 224. SAMEA Radioisotopes in Medicine Sales Price by Country (2021-2026) & (USD/t) Table 225. SAMEA Radioisotopes in Medicine Sales Price by Country (2027-2032) & (USD/t) Table 226. Brazil Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 227. Argentina Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 228. Chile Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 229. Colombia Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 230. Peru Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 231. Saudi Arabia Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 232. Israel Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 233. UAE Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 234. Turkey Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 235. Iran Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 236. Egypt Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Radioisotopes in Medicine Distributors List Table 240. Radioisotopes in Medicine Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Radioisotopes in Medicine Product Image Figure 2. Global Radioisotopes in Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radioisotopes in Medicine Market Size Share 2021 VS 2025 VS 2032 Figure . Tc-99m Image Figure 1. Iodine Radioisotopes Image Figure 2. Cobalt-60 Image Figure 3. Others Image Figure 4. Global Radioisotopes in Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 5. Global Radioisotopes in Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 6. Nuclear Therapy Image Figure 7. Equipment Radioactive Source Image Figure 8. Diagnosis Image Figure 9. Global Radioisotopes in Medicine Capacity, Capacity Utilization (2021-2032) & (t) Figure 10. Global Radioisotopes in Medicine Production by Region: 2021 VS 2025 VS 2032 (t) Figure 11. Global Radioisotopes in Medicine Production Market Share by Region: 2025 Versus 2032 Figure 12. Global Radioisotopes in Medicine Production Market Share by Region (2021-2032) Figure 13. North America Radioisotopes in Medicine Production Growth Rate (2021-2032) & (t) Figure 14. Europe Radioisotopes in Medicine Production Growth Rate (2021-2032) & (t) Figure 15. China Radioisotopes in Medicine Production Growth Rate (2021-2032) & (t) Figure 16. Japan Radioisotopes in Medicine Production Growth Rate (2021-2032) & (t) Figure 17. Global Radioisotopes in Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Radioisotopes in Medicine Revenue (2021-2032) & (US$ Million) Figure 19. Global Radioisotopes in Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Radioisotopes in Medicine Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Radioisotopes in Medicine Revenue Market Share by Region (2021-2032) Figure 22. Global Radioisotopes in Medicine Sales (2021-2032) & (t) Figure 23. Global Radioisotopes in Medicine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 24. Global Radioisotopes in Medicine Sales Market Share by Region (2021-2032) Figure 25. North America Radioisotopes in Medicine Sales YoY (2021-2032) & (t) Figure 26. Europe Radioisotopes in Medicine Sales YoY (2021-2032) & (t) Figure 27. China Radioisotopes in Medicine Sales YoY (2021-2032) & (t) Figure 28. Asia (Excluding China) Radioisotopes in Medicine Sales YoY (2021-2032) & (t) Figure 29. South America, Middle East and Africa Radioisotopes in Medicine Sales YoY (2021-2032) & (t) Figure 30. Global Radioisotopes in Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Radioisotopes in Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Radioisotopes in Medicine Revenue Market Share by Type (2021-2032) Figure 34. Global Radioisotopes in Medicine Sales Market Share by Type (2021-2032) Figure 35. Global Radioisotopes in Medicine Revenue Market Share by Application (2021-2032) Figure 36. Global Radioisotopes in Medicine Sales Market Share by Application (2021-2032) Figure 37. North America Radioisotopes in Medicine Revenue Share by Type (2021-2032) Figure 38. North America Radioisotopes in Medicine Sales Share by Type (2021-2032) Figure 39. North America Radioisotopes in Medicine Revenue Share by Application (2021-2032) Figure 40. North America Radioisotopes in Medicine Sales Share by Application (2021-2032) Figure 41. North America Radioisotopes in Medicine Revenue Share by Country (2021-2032) Figure 42. North America Radioisotopes in Medicine Sales Share by Country (2021-2032) Figure 43. Europe Radioisotopes in Medicine Revenue Share by Type (2021-2032) Figure 44. Europe Radioisotopes in Medicine Sales Share by Type (2021-2032) Figure 45. Europe Radioisotopes in Medicine Revenue Share by Application (2021-2032) Figure 46. Europe Radioisotopes in Medicine Sales Share by Application (2021-2032) Figure 47. Europe Radioisotopes in Medicine Revenue Share by Country (2021-2032) Figure 48. Europe Radioisotopes in Medicine Sales Share by Country (2021-2032) Figure 49. China Radioisotopes in Medicine Revenue Share by Type (2021-2032) Figure 50. China Radioisotopes in Medicine Sales Share by Type (2021-2032) Figure 51. China Radioisotopes in Medicine Revenue Share by Application (2021-2032) Figure 52. China Radioisotopes in Medicine Sales Share by Application (2021-2032) Figure 53. Asia Radioisotopes in Medicine Revenue Share by Type (2021-2032) Figure 54. Asia Radioisotopes in Medicine Sales Share by Type (2021-2032) Figure 55. Asia Radioisotopes in Medicine Revenue Share by Application (2021-2032) Figure 56. Asia Radioisotopes in Medicine Sales Share by Application (2021-2032) Figure 57. Asia Radioisotopes in Medicine Revenue Share by Country (2021-2032) Figure 58. Asia Radioisotopes in Medicine Sales Share by Country (2021-2032) Figure 59. SAMEA Radioisotopes in Medicine Revenue Share by Type (2021-2032) Figure 60. SAMEA Radioisotopes in Medicine Sales Share by Type (2021-2032) Figure 61. SAMEA Radioisotopes in Medicine Revenue Share by Application (2021-2032) Figure 62. SAMEA Radioisotopes in Medicine Sales Share by Application (2021-2032) Figure 63. SAMEA Radioisotopes in Medicine Revenue Share by Country (2021-2032) Figure 64. SAMEA Radioisotopes in Medicine Sales Share by Country (2021-2032) Figure 65. Radioisotopes in Medicine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Radioisotopes in Medicine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • Iodine Radioisotopes
  • Cobalt-60
  • Others
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
Companies covered
  • ANSTO
  • China National Nuclear Corporation
  • Eckert & Ziegler Strahlen
  • IRE
  • Nordion
  • NorthStar Medical Radioisotopes
  • NRG
  • NTP Radioisotopes
  • Polatom
  • Rosatom
  • SHINE Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radioisotopes in Medicine Market by Type
  3. 1.2.1 Global Radioisotopes in Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tc-99m
  5. 1.2.3 Iodine Radioisotopes
  6. 1.2.4 Cobalt-60
  7. 1.2.5 Others
  8. 1.3 Radioisotopes in Medicine Market by Application
  9. 1.3.1 Global Radioisotopes in Medicine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Nuclear Therapy
  11. 1.3.3 Equipment Radioactive Source
  12. 1.3.4 Diagnosis
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Radioisotopes in Medicine Market Dynamics
  1. 2.1 Radioisotopes in Medicine Industry Trends
  2. 2.2 Radioisotopes in Medicine Industry Drivers
  3. 2.3 Radioisotopes in Medicine Industry Opportunities and Challenges
  4. 2.4 Radioisotopes in Medicine Industry Restraints
3 Global Radioisotopes in Medicine Production Overview
  1. 3.1 Global Radioisotopes in Medicine Production Capacity (2021-2032)
  2. 3.2 Global Radioisotopes in Medicine Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Radioisotopes in Medicine Production by Region
  4. 3.3.1 Global Radioisotopes in Medicine Production by Region (2021-2026)
  5. 3.3.2 Global Radioisotopes in Medicine Production by Region (2027-2032)
  6. 3.3.3 Global Radioisotopes in Medicine Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Radioisotopes in Medicine Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Radioisotopes in Medicine Revenue by Region
  3. 4.2.1 Global Radioisotopes in Medicine Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Radioisotopes in Medicine Revenue by Region (2021-2026)
  5. 4.2.3 Global Radioisotopes in Medicine Revenue by Region (2027-2032)
  6. 4.2.4 Global Radioisotopes in Medicine Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Radioisotopes in Medicine Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Radioisotopes in Medicine Sales by Region
  9. 4.4.1 Global Radioisotopes in Medicine Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Radioisotopes in Medicine Sales by Region (2021-2026)
  11. 4.4.3 Global Radioisotopes in Medicine Sales by Region (2027-2032)
  12. 4.4.4 Global Radioisotopes in Medicine Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Radioisotopes in Medicine Revenue by Manufacturers
  2. 5.1.1 Global Radioisotopes in Medicine Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Radioisotopes in Medicine Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Radioisotopes in Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Radioisotopes in Medicine Sales by Manufacturers
  6. 5.2.1 Global Radioisotopes in Medicine Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Radioisotopes in Medicine Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Radioisotopes in Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Radioisotopes in Medicine Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Radioisotopes in Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Radioisotopes in Medicine Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Radioisotopes in Medicine Manufacturers, Product Type & Application
  13. 5.7 Global Radioisotopes in Medicine Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Radioisotopes in Medicine Market CR5 and HHI
  16. 5.8.2 2025 Radioisotopes in Medicine Tier 1, Tier 2, and Tier 3
6 Radioisotopes in Medicine Market by Type
  1. 6.1 Global Radioisotopes in Medicine Revenue by Type
  2. 6.1.1 Global Radioisotopes in Medicine Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Radioisotopes in Medicine Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Radioisotopes in Medicine Sales by Type
  5. 6.2.1 Global Radioisotopes in Medicine Sales by Type (2021-2032) & (t)
  6. 6.2.2 Global Radioisotopes in Medicine Sales Market Share by Type (2021-2032)
  7. 6.3 Global Radioisotopes in Medicine Price by Type
7 Radioisotopes in Medicine Market by Application
  1. 7.1 Global Radioisotopes in Medicine Revenue by Application
  2. 7.1.1 Global Radioisotopes in Medicine Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Radioisotopes in Medicine Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Radioisotopes in Medicine Sales by Application
  5. 7.2.1 Global Radioisotopes in Medicine Sales by Application (2021-2032) & (t)
  6. 7.2.2 Global Radioisotopes in Medicine Sales Market Share by Application (2021-2032)
  7. 7.3 Global Radioisotopes in Medicine Price by Application
8 Company Profiles
  1. 8.1 ANSTO
  2. 8.1.1 ANSTO Company Information
  3. 8.1.2 ANSTO Business Overview
  4. 8.1.3 ANSTO Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 ANSTO Radioisotopes in Medicine Product Portfolio
  6. 8.1.5 ANSTO Recent Developments
  7. 8.2 China National Nuclear Corporation
  8. 8.2.1 China National Nuclear Corporation Company Information
  9. 8.2.2 China National Nuclear Corporation Business Overview
  10. 8.2.3 China National Nuclear Corporation Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio
  12. 8.2.5 China National Nuclear Corporation Recent Developments
  13. 8.3 Eckert & Ziegler Strahlen
  14. 8.3.1 Eckert & Ziegler Strahlen Company Information
  15. 8.3.2 Eckert & Ziegler Strahlen Business Overview
  16. 8.3.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio
  18. 8.3.5 Eckert & Ziegler Strahlen Recent Developments
  19. 8.4 IRE
  20. 8.4.1 IRE Company Information
  21. 8.4.2 IRE Business Overview
  22. 8.4.3 IRE Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 IRE Radioisotopes in Medicine Product Portfolio
  24. 8.4.5 IRE Recent Developments
  25. 8.5 Nordion
  26. 8.5.1 Nordion Company Information
  27. 8.5.2 Nordion Business Overview
  28. 8.5.3 Nordion Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Nordion Radioisotopes in Medicine Product Portfolio
  30. 8.5.5 Nordion Recent Developments
  31. 8.6 NorthStar Medical Radioisotopes
  32. 8.6.1 NorthStar Medical Radioisotopes Company Information
  33. 8.6.2 NorthStar Medical Radioisotopes Business Overview
  34. 8.6.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio
  36. 8.6.5 NorthStar Medical Radioisotopes Recent Developments
  37. 8.7 NRG
  38. 8.7.1 NRG Company Information
  39. 8.7.2 NRG Business Overview
  40. 8.7.3 NRG Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 NRG Radioisotopes in Medicine Product Portfolio
  42. 8.7.5 NRG Recent Developments
  43. 8.8 NTP Radioisotopes
  44. 8.8.1 NTP Radioisotopes Company Information
  45. 8.8.2 NTP Radioisotopes Business Overview
  46. 8.8.3 NTP Radioisotopes Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 NTP Radioisotopes Radioisotopes in Medicine Product Portfolio
  48. 8.8.5 NTP Radioisotopes Recent Developments
  49. 8.9 Polatom
  50. 8.9.1 Polatom Company Information
  51. 8.9.2 Polatom Business Overview
  52. 8.9.3 Polatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Polatom Radioisotopes in Medicine Product Portfolio
  54. 8.9.5 Polatom Recent Developments
  55. 8.10 Rosatom
  56. 8.10.1 Rosatom Company Information
  57. 8.10.2 Rosatom Business Overview
  58. 8.10.3 Rosatom Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Rosatom Radioisotopes in Medicine Product Portfolio
  60. 8.10.5 Rosatom Recent Developments
  61. 8.11 SHINE Technologies
  62. 8.11.1 SHINE Technologies Company Information
  63. 8.11.2 SHINE Technologies Business Overview
  64. 8.11.3 SHINE Technologies Radioisotopes in Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 SHINE Technologies Radioisotopes in Medicine Product Portfolio
  66. 8.11.5 SHINE Technologies Recent Developments
9 North America
  1. 9.1 North America Radioisotopes in Medicine Market Size by Type
  2. 9.1.1 North America Radioisotopes in Medicine Revenue by Type (2021-2032)
  3. 9.1.2 North America Radioisotopes in Medicine Sales by Type (2021-2032)
  4. 9.1.3 North America Radioisotopes in Medicine Price by Type (2021-2032)
  5. 9.2 North America Radioisotopes in Medicine Market Size by Application
  6. 9.2.1 North America Radioisotopes in Medicine Revenue by Application (2021-2032)
  7. 9.2.2 North America Radioisotopes in Medicine Sales by Application (2021-2032)
  8. 9.2.3 North America Radioisotopes in Medicine Price by Application (2021-2032)
  9. 9.3 North America Radioisotopes in Medicine Market Size by Country
  10. 9.3.1 North America Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Radioisotopes in Medicine Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Radioisotopes in Medicine Market Size by Type
  2. 10.1.1 Europe Radioisotopes in Medicine Revenue by Type (2021-2032)
  3. 10.1.2 Europe Radioisotopes in Medicine Sales by Type (2021-2032)
  4. 10.1.3 Europe Radioisotopes in Medicine Price by Type (2021-2032)
  5. 10.2 Europe Radioisotopes in Medicine Market Size by Application
  6. 10.2.1 Europe Radioisotopes in Medicine Revenue by Application (2021-2032)
  7. 10.2.2 Europe Radioisotopes in Medicine Sales by Application (2021-2032)
  8. 10.2.3 Europe Radioisotopes in Medicine Price by Application (2021-2032)
  9. 10.3 Europe Radioisotopes in Medicine Market Size by Country
  10. 10.3.1 Europe Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Radioisotopes in Medicine Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Radioisotopes in Medicine Market Size by Type
  2. 11.1.1 China Radioisotopes in Medicine Revenue by Type (2021-2032)
  3. 11.1.2 China Radioisotopes in Medicine Sales by Type (2021-2032)
  4. 11.1.3 China Radioisotopes in Medicine Price by Type (2021-2032)
  5. 11.2 China Radioisotopes in Medicine Market Size by Application
  6. 11.2.1 China Radioisotopes in Medicine Revenue by Application (2021-2032)
  7. 11.2.2 China Radioisotopes in Medicine Sales by Application (2021-2032)
  8. 11.2.3 China Radioisotopes in Medicine Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Radioisotopes in Medicine Market Size by Type
  2. 12.1.1 Asia Radioisotopes in Medicine Revenue by Type (2021-2032)
  3. 12.1.2 Asia Radioisotopes in Medicine Sales by Type (2021-2032)
  4. 12.1.3 Asia Radioisotopes in Medicine Price by Type (2021-2032)
  5. 12.2 Asia Radioisotopes in Medicine Market Size by Application
  6. 12.2.1 Asia Radioisotopes in Medicine Revenue by Application (2021-2032)
  7. 12.2.2 Asia Radioisotopes in Medicine Sales by Application (2021-2032)
  8. 12.2.3 Asia Radioisotopes in Medicine Price by Application (2021-2032)
  9. 12.3 Asia Radioisotopes in Medicine Market Size by Country
  10. 12.3.1 Asia Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Radioisotopes in Medicine Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Radioisotopes in Medicine Market Size by Type
  2. 13.1.1 SAMEA Radioisotopes in Medicine Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Radioisotopes in Medicine Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Radioisotopes in Medicine Price by Type (2021-2032)
  5. 13.2 SAMEA Radioisotopes in Medicine Market Size by Application
  6. 13.2.1 SAMEA Radioisotopes in Medicine Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Radioisotopes in Medicine Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Radioisotopes in Medicine Price by Application (2021-2032)
  9. 13.3 SAMEA Radioisotopes in Medicine Market Size by Country
  10. 13.3.1 SAMEA Radioisotopes in Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Radioisotopes in Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Radioisotopes in Medicine Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Radioisotopes in Medicine Value Chain Analysis
  2. 14.1.1 Radioisotopes in Medicine Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Radioisotopes in Medicine Production Mode & Process
  6. 14.2 Radioisotopes in Medicine Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Radioisotopes in Medicine Distributors
  9. 14.2.3 Radioisotopes in Medicine Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst